This public procurement record has 6 releases in its history.

TenderUpdate

29 Jul 2026 at 11:47

Award

28 Jul 2026 at 17:54

Award

27 Mar 2024 at 09:49

Award

12 Sep 2023 at 10:04

TenderUpdate

27 Jun 2023 at 22:52

Tender

01 Jun 2023 at 17:48

Summary of the contracting process

Leidos Supply Limited is procuring the supply of medical gases for defence logistics on behalf of the UK Ministry of Defence. The requirement covers medical gases, including the medical oxygen and gas-cylinder capability needed to support the Ministry’s reserve. It is a goods contract for delivery across the United Kingdom, rather than a construction or professional-services opportunity. Leidos is the contracting organisation managing the requirement under its logistics commodities and services transformation delivery arrangements. The wider context is a consolidated gases supply strategy: medical gases are intended to align with related industrial, refrigerant, bulk and cryospeed gas requirements so that future demand can be managed through a more cohesive arrangement. The relevant business category is medical and industrial gas supply, classified under CPV 24111500.

This procurement has been awarded and the contract is active. BOC Limited was selected as the supplier for the medical gases requirement, with three active award records relating to it. The latest contract value is £13.75 million, while earlier contract records show £6 million; these are separate published values and must not be added together. The contract was signed on 26 August 2023, following an award process beginning on 3 July 2023, and the recorded contract period is 1,440 days. The original competition was an open procedure for four years from January 2024 to December 2027; the arrangement is being extended to 2030, with the current medical gases contract due to end on 31 December 2027 before that extension. The negotiated procedure without publication followed two unsuitable bids. Evaluation was on price alone, using a single-participant framework; variants were not allowed.

This outcome indicates demand for a sizeable, UK-wide medical-gas supply capability serving defence logistics, with particular relevance to suppliers able to provide the full range of required medical gases and maintain dependable gas-cylinder capacity. A credible competitor would need the operational scale to support a national requirement, robust distribution and logistics arrangements, and the ability to sustain supply over a multi-year framework. The buyer’s stated need for increased medical oxygen reserves, supported by supplier capital investment, points to value in cylinder fleet capacity, storage, replenishment and resilience planning. Suppliers should also be prepared for a procurement route involving negotiation after an unsuccessful open competition, and for price-led evaluation. Experience handling security-of-information requirements and adapting processes to changes in national security policy would support credibility with this defence-related buyer.

How relevant is this notice?

Notice Title

The Supply of Medical Gases

Notice Description

Team Leidos are proud to be delivering the logistics commodities and services transformation (LCS(T)) Delivery partner contracts (LCS (T)/0001 dated 16.4.2015) on behalf of the UK Ministry of Defence (the 'Prime Contract'). Delivery of other parts of the LCS(T) contract are delivered by Leidos Europe Ltd (LEL) and other partners (together 'Team Leidos'). This requirement is subject to the Public Procurement Regulations and respective advertising action.

Lot Information

Lot 1

This contract was originally tendered under PCR2015 using the Open Procedure in late 2023 for a 4-year contract (Jan 2024 - Dec 2027). The advertised Award Notice value for the contract was PS9.25M. It was one of 3 gas contracts awarded to BOC Limited by Leidos following 3 failed competitions. The current contract ("the Medical Gases Contract") is due to end on 31st December 2027. The other two contracts awarded to BOC were: (i) The Supply of Industrial Gases ("the Industrial Gases Contract") also under PCR, currently due to end also on 31st December 2027, and (ii) the contract for the Supply & Support of Refrigerant Gases, Bulk and Cryospeed Gases & Associated Equipment ("the Refrigerant Gases Contract") under DSPCR, which is due to end on 31st December 2030. Leidos now intends to extend both the Medical Gases Contract and the Industrial Gases Contract for 3 years to make their end dates coterminous with the Refrigerant Gases Contract in 2030 thereby enabling all three to be re-aggregated and let together in the future. Having attempted (unsuccessfully) to disaggregate the three requirements previously in the hope of generating more competition it is now felt that there is more logic in enabling a more consolidated, cost-effective and cohesive single gases tender approach. The proposed strategy allows time for further developments in the gases supply markets that could prevent a repeat of the failed tenders at the end of 2023. This new approach also eliminates the significant inconvenience and substantial duplication of costs for the contracting authority of running three tenders rather than a single consolidated one. To facilitate the proposed contract extension, it is proposed to modify the value of the Framework Contract originally awarded to BOC ( original value PS9.25m) to PS13.75m on the basis that the provisions of PCR Regulation 72 (Modification of Contracts during their term): 72 (1) (b): apply- i.e.: " ...Contracts and framework agreements may be modified without a new procurement procedure ..... for additional works services or supplies by the original contractor that have become necessary and were not included in the initial procurement where a change of contractor: (i) cannot be made for economic or technical reasons such as requirements of interchangeability or interoperability with existing equipment, services or installations procured under the original procurement and (ii) would cause significant inconvenience or substantial duplication of costs for the contracting authority ..provided that any increase in price does not exceed 50% of the value of the original contract. Future demand under the extended contract is difficult to determine accurately but is likely to be affected by a (separate) increase in the MOD's Medical oxygen gas cylinders reserve supported by supplier capital investment. Call offs under the extended framework will be monitored and, if it is anticipated that the revised framework value might be exceeded a further VEAT will be published.

Procurement Information

This contract was originally tendered under PCR2015 using the Open Procedure in late 2023 for a 4-year contract (Jan 2024 - Dec 2027). The advertised Award Notice value for the contract was PS9.25M. It was one of 3 gas contracts awarded to BOC Limited by Leidos following 3 failed competitions. The current contract ("the Medical Gases Contract") is due to end on 31st December 2027. The other two contracts awarded to BOC were: (i) The Supply of Industrial Gases ("the Industrial Gases Contract") also under PCR, currently due to end also on 31st December 2027, and (ii) the contract for the Supply & Support of Refrigerant Gases, Bulk and Cryospeed Gases & Associated Equipment ("the Refrigerant Gases Contract") under DSPCR, which is due to end on 31st December 2030. Leidos now intends to extend both the Medical Gases Contract and the Industrial Gases Contract for 3 years to make their end dates coterminous with the Refrigerant Gases Contract in 2030 thereby enabling all three to be re-aggregated and let together in the future. Having attempted (unsuccessfully) to disaggregate the three requirements previously in the hope of generating more competition it is now felt that there is more logic in enabling a more consolidated, cost-effective and cohesive single gases tender approach. The proposed strategy allows time for further developments in the gases supply markets that could prevent a repeat of the failed tenders at the end of 2023. This new approach also eliminates the significant inconvenience and substantial duplication of costs for the contracting authority of running three tenders rather than a single consolidated one. To facilitate the proposed contract extension, it is proposed to modify the value of the Framework Contract originally awarded to BOC ( original value PS9.25m) to PS13.75m on the basis that the provisions of PCR Regulation 72 (Modification of Contracts during their term): 72 (1) (b): apply- i.e.: " ...Contracts and framework agreements may be modified without a new procurement procedure ..... for additional works services or supplies by the original contractor that have become necessary and were not included in the initial procurement where a change of contractor: (i) cannot be made for economic or technical reasons such as requirements of interchangeability or interoperability with existing equipment, services or installations procured under the original procurement and (ii) would cause significant inconvenience or substantial duplication of costs for the contracting authority ..provided that any increase in price does not exceed 50% of the value of the original contract. Future demand under the extended contract is difficult to determine accurately but is likely to be affected by a (separate) increase in the MOD's Medical oxygen gas cylinders reserve supported by supplier capital investment. Call offs under the extended framework will be monitored and, if it is anticipated that the revised framework value might be exceeded a further VEAT will be published.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-03d31c
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/071621-2026
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Limited
Procurement Method Details
Negotiated without publication of a contract notice
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

24 - Chemical products


CPV Codes

24100000 - Gases

24111500 - Medical gases

Notice Value(s)

Tender Value
£6,000,000 £1M-£10M
Lots Value
£6,000,000 £1M-£10M
Awards Value
Not specified
Contracts Value
£19,750,000 £10M-£100M

Notice Dates

Publication Date
29 Jul 20264 weeks ago
Submission Deadline
3 Jul 2023Expired
Future Notice Date
Not specified
Award Date
26 Jul 20233 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
Leidos Supply Limited
Additional Buyers

Leidos Supply

Ministry of Defence

Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
BRISTOL
Postcode
BS16 7FH
Postcode Area
Bristol
Country
England

Major Region (ITL 1)
TLK South West (England)
Basic Region (ITL 2)
TLK5 West of England
Small Region (ITL 3)
TLK52 Bath & North East Somerset and South Gloucestershire
Delivery Location
Not specified

Local Authority
South Gloucestershire
Electoral Ward
Emersons Green
Westminster Constituency
Filton and Bradley Stoke

Supplier Information

Number of Suppliers
1
Supplier Name

BOC Limited

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...